iBio, Inc.
NASDAQ:IBIOBiotechnology
+$0.00 today
- Market cap
- $59.75M
- Beta
- 1.29
- P/E (TTM)
- -3.6
- EPS (TTM)
- -$0.32
Volume 0.84M
Average 0.81M
IBIO Total Current Assets
All assets expected to be converted to cash or used up within one year.
iBio, Inc.NASDAQ: IBIO
Total Current Assets · Q4 FY2026 · quarter ended Jun 2026
Total current assets rises 848.7% from a year ago
Total current assets stood at $92.22M at the end of Q4 FY2026, up 848.7% from a year earlier and up 19.4% from the prior quarter. Over 3 fiscal years it compounded at +52.0% a year.
Context
- Total current assets amounted to 93.0% of total assets at the end of Q4 FY2026, up 51.1 pp from a year earlier.
- Total current assets increased in 1 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current assets keeps rising in the next quarterly balance sheet after a +848.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2026
- 92.22M USD
- Year-over-year change
- +848.7%
- 4-year CAGR
- +19.6%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | 92.22M | +848.7% |
| FY2025 | 2025-06-30 | 9.72M | -38.0% |
| FY2024 | 2024-06-30 | 15.67M | -40.3% |
| FY2023 | 2023-06-30 | 26.26M | -41.7% |
| FY2022 | 2022-06-30 | 45.07M | — |
Total Current Assets vs competitors
How IBIO compares with its peers on the latest reported figures
- IBIO's Jun 2026 total current assets of $92.22M is the 2nd highest of the 4 companies compared; the peer median is $87.49M.
- Its year-over-year change of +848.7% is the highest of 4, against a peer median of -6.8%.
- Total current assets amounts to 93.0% of total assets for IBIO, versus a peer median of 98.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $94.62M | -32.6% | +17.2% | 67.1% | |
| Jun 2026 | $92.22M | +848.7% | +52.0% | 93.0% | |
| Mar 2026 | $87.49M | +25.8% | -15.3% | 100.0% | |
| Mar 2026 | $53.49M | -6.8% | -30.1% | 98.2% | |
| Peer median (excluding IBIO) | $87.49M | -6.8% | -15.3% | 98.2% | |
Competitors are the stored peer set for IBIO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 22.68M | 7.33M | 14.21M | 8.58M | 56.4M |
| Short-term Investments | 10.85M | 0 | 0 | 0 | 31.64M |
| Net Receivables | 6.1M | 204K | 713K | 105K | 1.1M |
| Inventory | 3.9M | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 18.73M | 749K | 1.03M | 3.08M |
| Total Current Assets | 45.07M | 26.26M | 15.67M | 9.72M | 92.22M |
| Property, Plant & Equipment (Net) | 41.76M | 7.55M | 6.37M | 5.28M | 4.75M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 4.85M | 5.39M | 5.37M | 6.85M | 1.83M |
| Long-term Investments | 7.63M | 1.96M | 1.3M | 1.31M | 228K |
| Tax Assets | (7.63M) | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 7.73M | 50K | 26K | 26K | 83K |
| Total Non-current Assets | 54.34M | 14.95M | 13.06M | 13.46M | 6.89M |
| Total Assets | 99.41M | 41.21M | 28.73M | 23.19M | 99.11M |
| Account Payables | 4.26M | 1.85M | 358K | 2.19M | 4.42M |
| Short-term Debt | 22.16M | 13.6M | 218K | 766K | 0 |
| Tax Payables | 284K | 268K | 0 | 0 | 0 |
| Deferred Revenue | 100K | 0 | 200K | 1.2M | 0 |
| Other Current Liabilities | 754K | 2.52M | 761K | 876K | 6.78M |
| Total Current Liabilities | 30.44M | 21.58M | 3.84M | 6.11M | 11.75M |
| Long-term Debt | 0 | 0 | 766K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.97M | 768K | 63K | 0 | 0 |
| Total Non-current Liabilities | 5.49M | 4.24M | 3.57M | 2.2M | 1.65M |
| Total Liabilities | 35.92M | 25.83M | 7.41M | 8.31M | 13.4M |
| Common Stock | 9K | 20K | 9K | 19K | 56K |
| Retained Earnings | (223.93M) | (288.94M) | (313.85M) | (332.22M) | (365.27M) |
| Accumulated OCI | (213K) | 0 | 0 | 0 | (45K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 63.49M | 15.38M | 21.32M | 14.88M | 85.71M |
| Total Debt | 25.77M | 17.07M | 4.46M | 3.51M | 2.2M |
| Net Debt | 3.09M | 9.75M | (9.75M) | (5.07M) | (54.2M) |
iBio, Inc.
NASDAQ:IBIO
Intrinsic Alpha fair value
Locked
Current Price
$0.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.